Galectin Therapeutics Inc.
GALT
$1.38
$0.010.73%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 15.12M | 27.06M | 25.60M | 23.56M | 25.66M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.03M | 1.61M | 1.69M | 1.91M | 2.04M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.11M | -- | -- | -- | 6.00K |
| Total Current Assets | 17.25M | 28.67M | 27.29M | 25.46M | 27.71M |
|
|
|||||
| Total Current Assets | 17.25M | 28.67M | 27.29M | 25.46M | 27.71M |
| Net Property, Plant & Equipment | 16.00K | 26.00K | 35.00K | 45.00K | 46.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 227.00K | 280.00K | 333.00K | 385.00K | 444.00K |
| Total Assets | 17.50M | 28.97M | 27.66M | 25.89M | 28.20M |
|
|
|||||
| Total Accounts Payable | 5.66M | 2.80M | 3.70M | 3.80M | 6.43M |
| Total Accrued Expenses | 8.19M | 11.55M | 10.81M | 8.79M | 9.14M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 21.14M | 10.55M | 44.00K | 48.00K | 46.00K |
| Total Finance Division Other Current Liabilities | 432.00K | 359.00K | 63.00K | -- | 63.00K |
| Total Other Current Liabilities | 432.00K | 359.00K | 63.00K | -- | 63.00K |
| Total Current Liabilities | 35.41M | 25.26M | 14.62M | 12.63M | 15.68M |
|
|
|||||
| Total Current Liabilities | 35.41M | 25.26M | 14.62M | 12.63M | 15.68M |
| Long-Term Debt | 85.11M | 94.04M | 93.42M | 84.34M | 71.74M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | 7.00K | 20.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 47.00K | 2.16M | 1.76M | -- | 1.00M |
| Total Liabilities | 120.57M | 121.45M | 109.80M | 96.98M | 88.44M |
|
|
|||||
| Common Stock & APIC | 296.28M | 294.84M | 293.93M | 292.56M | 291.91M |
| Retained Earnings | -401.57M | -389.54M | -378.30M | -365.87M | -354.37M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -105.29M | -94.70M | -84.37M | -73.31M | -62.46M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 2.22M | 2.22M | 2.22M | 2.22M | 2.22M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 2.22M | 2.22M | 2.22M | 2.22M | 2.22M |
|
|
|||||
| Total Common Equity | -105.29M | -94.70M | -84.37M | -73.31M | -62.46M |
| Total Preferred Equity | 2.22M | 2.22M | 2.22M | 2.22M | 2.22M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -103.07M | -92.48M | -82.15M | -71.09M | -60.24M |
|
|
|||||